Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation.
Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation.
复制标题
DOI:
10.1016/j.cell.2022.04.005
复制
发表时间:
2022-05-12
期刊:
影响因子:
64.5
通讯作者:
Wu, Joseph C.
中科院分区:
文献类型:
--
作者:
Wei, Tzu-Tang;Chandy, Mark;Nishiga, Masataka;Zhang, Angela;Kumar, Kaavya Krishna;Thomas, Dilip;Manhas, Amit;Rhee, Siyeon;Justesen, Johanne Marie;Chen, Ian Y.;Wo, Hung-Ta;Khanamiri, Saereh;Yang, Johnson Y.;Seidl, Frederick J.;Burns, Noah Z.;Liu, Chun;Sayed, Nazish;Shie, Jiun-Jie;Yeh, Chih-Fan;Yang, Kai-Chien;Lau, Edward;Lynch, Kara L.;Rivas, Manuel;Kobilka, Brian K.;Wu, Joseph C.
Epidemiological studies reveal that marijuana increases the risk of cardiovascular disease (CVD); however, little is known about the mechanism. Δ9-tetrahydrocannabinol (Δ9-THC), the psychoactive component of marijuana, binds to cannabinoid receptor 1 (CB1/CNR1) in the vasculature and is implicated in CVD. A UK Biobank analysis found that cannabis was an risk factor for CVD. We found that marijuana smoking activated inflammatory cytokines implicated in CVD. In silico virtual screening identified genistein, a soybean isoflavone, as a putative CB1 antagonist. Human-induced pluripotent stem cell-derived endothelial cells were used to model Δ9-THC-induced inflammation and oxidative stress via NF-κB signaling. Knockdown of the CB1 receptor with siRNA, CRISPR interference, and genistein attenuated the effects of Δ9-THC. In mice, genistein blocked Δ9-THC-induced endothelial dysfunction in wire myograph, reduced atherosclerotic plaque, and had minimal penetration of the central nervous system. Genistein is a CB1 antagonist that attenuates Δ9-THC-induced atherosclerosis. Marijuana use is on the rise and is associated with cardiovascular disease. Δ9-tetrahydrocannabinol (Δ9-THC), the psychedelic component of marijuana, causes vascular inflammation, oxidative stress, and atherosclerosis via cannabinoid receptor 1. Genistein, a soybean isoflavone, blocks harmful cardiovascular effects of Δ9-THC while preserving clinically useful effects such as sedation and analgesia.
登录
查看更多内容
影响因子:
64.8
作者:
Bycroft C;Freeman C;Petkova D;Band G;Elliott LT;Sharp K;Motyer A;Vukcevic D;Delaneau O;O'Connell J;Cortes A;Welsh S;Young A;Effingham M;McVean G;Leslie S;Allen N;Donnelly P;Marchini J
通讯作者:
Marchini J
影响因子:
24
作者:
DeFilippis EM;Singh A;Divakaran S;Gupta A;Collins BL;Biery D;Qamar A;Fatima A;Ramsis M;Pipilas D;Rajabi R;Eng M;Hainer J;Klein J;Januzzi JL;Nasir K;Di Carli MF;Bhatt DL;Blankstein R
通讯作者:
Blankstein R
影响因子:
20.8
作者:
Chen, Pei-Yu;Qin, Lingfeng;Simons, Michael
通讯作者:
Simons, Michael
影响因子:
4.6
作者:
Ardigo, Diego;Assimes, Themistocles L.;Quertermous, Thomas
通讯作者:
Quertermous, Thomas
影响因子:
32.4
作者:
Choi, Jae-Hoon;Cheong, Cheolho;Steinman, Ralph M.
通讯作者:
Steinman, Ralph M.